Works in Alimentary Pharmacology & Therapeutics, 2019, Vol 50, Issue 7

Results: 28

Editorial: when, who and how—the ever‐evolving management of pancreatic cystic lesions. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 829, doi. 10.1111/apt.15492

By:

Overbeek, Kasper A.;
Cahen, Djuna L.;
Bruno, Marco J.

Publication type:

Article

Letter: metformin treatment and hepatocellular carcinoma risk in non‐alcoholic fatty liver disease. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 836, doi. 10.1111/apt.15488

By:

Vilar‐Gomez, Eduardo;
Chalasani, Naga

Publication type:

Article

Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 838, doi. 10.1111/apt.15486

By:

Vilar‐Gomez, Eduardo;
Chalasani, Naga

Publication type:

Article

Letter: anti‐TNF therapy and intestinal resections in Crohn's disease—are we just delaying the inevitable?

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 842, doi. 10.1111/apt.15482

By:

Ashton, James J.;
Beattie, R. Mark

Publication type:

Article

Review article: direct‐acting antivirals for the treatment of HCV during pregnancy and lactation ‐ implications for maternal dosing, foetal exposure, and safety for mother and child.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 738, doi. 10.1111/apt.15476

By:

Freriksen, Jolien J. M.;
Seyen, Minou;
Judd, Ali;
Gibb, Diana M.;
Collins, Intira J.;
Greupink, Rick;
Russel, Frans G. M.;
Drenth, Joost P. H.;
Colbers, Angela;
Burger, David M.

Publication type:

Article

Editorial: the reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food reintroduction.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 824, doi. 10.1111/apt.15475

By:

Wall, Catherine L.;
Day, Andrew S.

Publication type:

Article

Letter: predictors of survival in patients undergoing transjugular intrahepatic portosystemic shunt—what should we assess by ultrasound?

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 841, doi. 10.1111/apt.15468

By:

Yuan, Shuai;
Yang, Xiaomin;
Chen, Jin;
Zhao, Shenggang;
Xu, Jianjiang;
Liang, Chun

Publication type:

Article

Editorial: when, who and how—the ever evolving management of pancreatic cystic lesions.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 828, doi. 10.1111/apt.15471

By:

Yang, Dennis;
Forsmark, Chris E.

Publication type:

Article

Editorial: liver test abnormalities in oncology patients in the age of the checkpoint inhibitors.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 831, doi. 10.1111/apt.15473

By:

Rich, Nicole E.;
Lee, William M.

Publication type:

Article

Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 837, doi. 10.1111/apt.15467

By:

Huo, Rong‐Rui;
Liang, Jing‐Rong;
He, Feng‐Yi;
Xu, Bin‐Rong;
Ma, Liang;
Yuan, Wei‐Ping

Publication type:

Article

Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 760, doi. 10.1111/apt.15466

By:

Min, Yang Won;
Kang, Danbee;
Shin, Ju‐Young;
Kang, Minwoong;
Park, Joo Kyung;
Lee, Kwang Hyuck;
Lee, Jong Kyun;
Lee, Kyu Taek;
Rhee, Poong‐Lyul;
Kim, Jae J.;
Guallar, Eliseo;
Cho, Juhee;
Lee, Hyuk

Publication type:

Article

Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea—are we any closer? Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 826, doi. 10.1111/apt.15465

By:

Gunn, David;
Garsed, Klara;
Lam, Ching;
Singh, Gulzar;
Lingaya, Melanie;
Wahl, Verena;
Niesler, Beate;
Henry, Amanda;
Hall, Ian;
Whorwell, Peter;
Spiller, Robin

Publication type:

Article

Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 809, doi. 10.1111/apt.15464

By:

Gawrieh, Samer;
Dakhoul, Lara;
Miller, Ethan;
Scanga, Andrew;
deLemos, Andrew;
Kettler, Carla;
Burney, Heather;
Liu, Hao;
Abu‐Sbeih, Hamzah;
Chalasani, Naga;
Wattacheril, Julia

Publication type:

Article

Increased risk of thiopurine‐related adverse events in elderly patients with IBD.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 780, doi. 10.1111/apt.15458

By:

Calafat, Margalida;
Mañosa, Míriam;
Cañete, Fiorella;
Ricart, Elena;
Iglesias, Eva;
Calvo, Marta;
Rodríguez‐Moranta, Francisco;
Taxonera, Carlos;
Nos, Pilar;
Mesonero, Francisco;
Martín‐Arranz, María-Dolores;
Mínguez, Miguel;
Gisbert, Javier P.;
García‐López, Santiago;
de Francisco, Ruth;
Gomollón, Fernando;
Calvet, Xavier;
Garcia‐Planella, Esther;
Rivero, Montserrat;
Martínez‐Cadilla, Jesús

Publication type:

Article

Letter: metformin treatment and hepatocellular carcinoma risk in non‐alcoholic fatty liver disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 835, doi. 10.1111/apt.15462

By:

Dogru, Teoman;
Kırık, Ali;
Sonmez, Alper

Publication type:

Article

Letter: hepatocellular carcinoma surveillance determines survival in patients at risk.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 839, doi. 10.1111/apt.15461

By:

Zhu, Shao‐Liang;
Li, Yuan‐Qi;
Hu, Hui;
Ma, Liang

Publication type:

Article

Editorial: anti‐TNF therapy—a double‐edged sword? Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 823, doi. 10.1111/apt.15459

By:

Korzenik, Joshua;
Larsen, Michael Due;
Nielsen, Jan;
Kjeldsen, Jens;
Nørgård, Bente Mertz

Publication type:

Article

Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti‐TNFα agents, particularly etanercept, for autoimmune diseases other than IBD.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 834, doi. 10.1111/apt.15460

By:

Dai, Cong;
Jiang, Min;
Sun, Ming‐Jun

Publication type:

Article

Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea—are we any closer?

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 825, doi. 10.1111/apt.15455

By:

Black, Christopher J.;
Ford, Alexander C.;
Houghton, Lesley A.

Publication type:

Article

Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 769, doi. 10.1111/apt.15446

By:

Choi, Yoon Jin;
Lee, Dong Ho;
Shin, Dong Woo;
Han, Kyung‐Do;
Yoon, Hyuk;
Shin, Cheol Min;
Park, Young Soo;
Kim, Nayoung

Publication type:

Article

Editorial: the problem of supragastric belching needs to be heard.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 832, doi. 10.1111/apt.15454

By:

Halland, Magnus;
Katzka, David A.

Publication type:

Article

Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 789, doi. 10.1111/apt.15440

By:

Overbeek, Kasper A.;
Alblas, Maaike;
Gausman, Valerie;
Kandel, Pujan;
Schweber, Adam B.;
Brooks, Christian;
Van Riet, Priscilla A.;
Wallace, Michael B.;
Gonda, Tamas A.;
Cahen, Djuna L.;
Bruno, Marco J.

Publication type:

Article

Editorial: depression in NAFLD—worth looking for.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 830, doi. 10.1111/apt.15453

By:

Parker, Richard

Publication type:

Article

Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ‐12420), a novel potassium‐competitive acid blocker, in healthy male subjects.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 751, doi. 10.1111/apt.15438

By:

Han, Sungpil;
Choi, Hee Youn;
Kim, Yo Han;
Nam, Ji Yeon;
Kim, Bongtae;
Song, Geun Seog;
Lim, Hyeong‐Seok;
Bae, Kyun‐Seop

Publication type:

Article

Review article: the role of the autonomic nervous system in the pathogenesis and therapy of IBD.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 720, doi. 10.1111/apt.15433

By:

Mogilevski, Tamara;
Burgell, Rebecca;
Aziz, Qasim;
Gibson, Peter R.

Publication type:

Article

Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 800, doi. 10.1111/apt.15413

By:

Tsung, Irene;
Dolan, Russell;
Lao, Christopher D.;
Fecher, Leslie;
Riggenbach, Kane;
Yeboah‐Korang, Amoah;
Fontana, Robert J.

Publication type:

Article

Editorial: anti‐TNF therapy—a double‐edged sword?

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 822, doi. 10.1111/apt.15401

By:

Schreiner, Philipp;
Biedermann, Luc

Publication type:

Article

Issue Information.

Published in:: Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 717, doi. 10.1111/apt.14886
Publication type:: Article